Florence Jouan

1.4k total citations
36 papers, 812 citations indexed

About

Florence Jouan is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Florence Jouan has authored 36 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 18 papers in Molecular Biology and 11 papers in Cancer Research. Recurrent topics in Florence Jouan's work include Renal cell carcinoma treatment (16 papers), Renal and related cancers (9 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Florence Jouan is often cited by papers focused on Renal cell carcinoma treatment (16 papers), Renal and related cancers (9 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Florence Jouan collaborates with scholars based in France, United States and United Kingdom. Florence Jouan's co-authors include Cécile Vigneau, Nicolas Collet, Thibault Dolley‐Hitze, Yannick Arlot‐Bonnemains, Patricia Fergelot, G. Verhoest, Emmanuel Oger, Marc‐Antoine Belaud‐Rotureau, Karim Bensalah and Audrey Lavenu and has published in prestigious journals such as Nature, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Florence Jouan

35 papers receiving 806 citations

Peers

Florence Jouan

PRM

ONCOL

IMMUN

Fei Teng China

Maria Gomolka Germany

Afshan Dean United Kingdom

Ronald Allan M. Panganiban United States

Wenying Liang United States

Guangliang Chen China

Gang Han China

Meng Ye China

Pingping Gao China

Koichi Fujisawa Japan

Fei Teng China

Florence Jouan

637 ×1.6

104 ×0.4

PRM

297 ×1.6

93 ×0.9

ONCOL

126 ×1.7

IMMUN

Citations per year, relative to Florence Jouan Florence Jouan (= 1×) peers Fei Teng

Countries citing papers authored by Florence Jouan

Since Specialization

Citations

This map shows the geographic impact of Florence Jouan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florence Jouan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florence Jouan more than expected).

Fields of papers citing papers by Florence Jouan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florence Jouan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florence Jouan. The network helps show where Florence Jouan may publish in the future.

Co-authorship network of co-authors of Florence Jouan

This figure shows the co-authorship network connecting the top 25 collaborators of Florence Jouan. A scholar is included among the top collaborators of Florence Jouan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florence Jouan. Florence Jouan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Léonard, Simon, Camille Laurent, Céline Monvoisin, et al.. (2025). Lymphoma B cells remodel bone marrow stromal cells into extracellular matrix–producing cancer-associated fibroblasts. Blood Advances. 9(14). 3455–3468. 1 indexed citations

Sibut, Vonick, Saba Nayar, Céline Monvoisin, et al.. (2023). KDM6B drives epigenetic reprogramming associated with lymphoid stromal cell early commitment and immune properties. Science Advances. 9(48). eadh2708–eadh2708. 5 indexed citations

Ricordel, Charles, Marc Aubry, Florence Jouan, et al.. (2023). Genomic characteristics and clinical significance of CD56+ circulating tumor cells in small cell lung cancer. Scientific Reports. 13(1). 3626–3626. 4 indexed citations

Rogier, Mélanie, Isabelle Robert, Chloé Lescale, et al.. (2021). Fam72a enforces error-prone DNA repair during antibody diversification. Nature. 600(7888). 329–333. 32 indexed citations

Laffleur, Brice, Florence Jouan, Jeanne Cook‐Moreau, et al.. (2021). UnAIDed Class Switching in Activated B-Cells Reveals Intrinsic Features of a Self-Cleaving IgH Locus. Frontiers in Immunology. 12. 737427–737427. 4 indexed citations

Ricordel, Charles, Florence Jouan, Agnès Burel, et al.. (2021). ING2 tumor suppressive protein translocates into mitochondria and is involved in cellular metabolism homeostasis. Oncogene. 40(24). 4111–4123. 7 indexed citations

Nguyen, Ha Thanh, Jean‐Philippe Guégan, Amanda Poissonnier, et al.. (2019). Synthesis of peptidomimetics and chemo-biological tools for CD95/PLCγ1 interaction analysis. Bioorganic & Medicinal Chemistry Letters. 29(16). 2094–2099. 2 indexed citations

Poissonnier, Amanda, Jean‐Philippe Guégan, Ha Thanh Nguyen, et al.. (2018). Disrupting the CD95–PLCγ1 interaction prevents Th17-driven inflammation. Nature Chemical Biology. 14(12). 1079–1089. 25 indexed citations

Avril, Tony, Amandine Etcheverry, Raphaël Pineau, et al.. (2017). CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma. Clinical Cancer Research. 23(23). 7360–7374. 34 indexed citations

10.

Chesnel, Franck, Jean‐Philippe Gagné, Antoine Couturier, et al.. (2015). The von Hippel–Lindau tumour suppressor gene: uncovering the expression of the pVHL172 isoform. British Journal of Cancer. 113(2). 336–344. 16 indexed citations

11.

Martin, Bénédicte, Franck Chesnel, Jean‐Guy Delcros, et al.. (2014). Correction: Identification of pVHL as a Novel Substrate for Aurora-A in Clear Cell Renal Cell Carcinoma (ccRCC). PLoS ONE. 9(1). 2 indexed citations

12.

Dolley‐Hitze, Thibault, G. Verhoest, Florence Jouan, et al.. (2013). Récepteurs de type 1 à l’angiotensine-2 (AT1R) et cancers. Néphrologie & Thérapeutique. 9(2). 85–91. 5 indexed citations

13.

Martin, Bénédicte, Julien Edeline, Jean‐Jacques Patard, et al.. (2012). Combination of Temsirolimus and tyrosine kinase inhibitors in renal carcinoma and endothelial cell lines. Journal of Cancer Research and Clinical Oncology. 138(6). 907–916. 10 indexed citations

14.

Dolley‐Hitze, Thibault, Florence Jouan, Bénédicte Martin, et al.. (2010). Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma?. British Journal of Cancer. 103(11). 1698–1705. 67 indexed citations

15.

Verhoest, G., Jean‐Jacques Patard, Patricia Fergelot, et al.. (2010). Paraffin-embedded tissue is less accurate than frozen section analysis for determining VHL mutational status in sporadic renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 30(4). 469–475. 6 indexed citations

16.

Masson, Damien, Patricia Fergelot, Florence Jouan, et al.. (2010). Loss of expression of TIMP3 in clear cell renal cell carcinoma. European Journal of Cancer. 46(8). 1430–1437. 44 indexed citations

17.

Patard, Jean‐Jacques, Damien Masson, Florence Jouan, et al.. (2009). Absence of VHL gene alteration and high VEGF expression are associated with tumour aggressiveness and poor survival of renal-cell carcinoma. British Journal of Cancer. 101(8). 1417–1424. 74 indexed citations

18.

Rébillard, Amélie, N. Costedoat‐Chalumeau, Carolyn Y. Muller, et al.. (2008). Acid sphingomyelinase deficiency protects from cisplatin-induced gastrointestinal damage. Oncogene. 27(51). 6590–6595. 33 indexed citations

19.

Fergelot, Patricia, Emmanuelle Leray, Florence Jouan, et al.. (2007). Plasma level and tissue expression of vascular endothelial growth factor in renal cell carcinoma: a prospective study of 50 cases. Human Pathology. 38(10). 1489–1495. 42 indexed citations

20.

Delcros, Jean‐Guy, Jean‐Yves Bansard, Jonathan I. Epstein, et al.. (2004). Immunohistochemical analysis of tumor polyamines discriminates high-risk patients undergoing nephrectomy for renal cell carcinoma. Human Pathology. 35(10). 1279–1284. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact